Associations Between Dysbiosis Gut Microbiota and Changes of Neurotransmitters and Short-chain Fatty Acids in Valproic Acid Model Rats

Overview

Journal Front Physiol

Date 2023 Apr 10

PMID 37035670

Authors

Jiu-Gen Zhong

Wan-Ting Lan

Yan-Qing Feng

Yin-Hua Li

Ying-Ying Shen

Jia-Heng Gong

Zhi Zou

Xiaohui Hou

Affiliations

Soon will be listed here.

Abstract

The microbiota-gut-brain axis plays an important role in the pathophysiology of autism spectrum disorder, but its specific mechanisms remain unclear. This study aimed to explore the associations of changes in neurotransmitters and short-chain fatty acids with alterations in gut microbiota in valproic acid model rats. The autism model rats were established by prenatal exposure to valproic acid (VPA). The Morris water maze test, open field test, and three-chamber test were conducted to assess the behaviors of rats. 16S rRNA gene sequences extracted from fecal samples were used to assess the gut microbial composition. Gas and liquid chromatography-mass spectroscopy was used to identify short-chain fatty acids in fecal samples and neurotransmitters in the prefrontal cortex (PFC). The results showed that 28 bacterial taxa between valproic acid model rats and control rats were identified, and the most differential bacterial taxa in valproic acid model rats and control rats belonged to metagenomic species and . Acetic acid, butyric acid, valeric acid, isobutyric acid, and isovaleric acid were significantly decreased in the valproic acid model rats compared to those in control rats. Five neurotransmitters (threonine, kynurenine, tryptophan, 5-hydroxyindoleacetic acid, denoted as 5-HIAA, and betaine aldehyde chloride, denoted as BAC) were significantly decreased, whereas betaine was increased in the prefrontal cortex of valproic acid model rats compared to control rats. A variety of neurotransmitters (≥4) were correlated with , and at the genus level, and they were also related to the decrease of short-chain fatty acids. According to this study, we can preliminarily infer that gut microbiota or their metabolic productions (such as SCFAs) may influence central neurotransmitter metabolism through related pathways of the gut-brain axis. These results provide microbial and short-chain fatty acid (SCFA) frameworks for understanding the role of the microbiota-gut-brain axis in autism spectrum disorder and shed new light on autism spectrum disorder treatment.

Citing Articles

The Neonatal Microbiome: Implications for Amyotrophic Lateral Sclerosis and Other Neurodegenerations.

Eisen A, Kiernan M Brain Sci. 2025; 15(2).

PMID: 40002527 PMC: 11852589. DOI: 10.3390/brainsci15020195.

Multi-omics insights into the microbiota-gut-brain axis and cognitive improvement post-bariatric surgery.

Xiang Q, Yu M, Cai Q, Hu M, Rao B, Liang X J Transl Med. 2024; 22(1):945.

PMID: 39420319 PMC: 11484437. DOI: 10.1186/s12967-024-05757-9.

Gut microbiota of children with autism spectrum disorder and healthy siblings: A comparative study.

Abuljadayel D, Alotibi A, Algothmi K, Basingab F, Alhazmi S, Almuhammadi A Exp Ther Med. 2024; 28(5):430.

PMID: 39328398 PMC: 11425773. DOI: 10.3892/etm.2024.12719.

Effect of Dietary Sugarcane Bagasse on Reproductive Performance, Constipation, and Gut Microbiota of Gestational Sows.

Huang R, Zhang B, Wang J, Zhao W, Huang Y, Liu Y Animals (Basel). 2024; 14(17).

PMID: 39272308 PMC: 11393912. DOI: 10.3390/ani14172523.

Interaction of Heavy Metal Lead with Gut Microbiota: Implications for Autism Spectrum Disorder.

Tizabi Y, Bennani S, El Kouhen N, Getachew B, Aschner M Biomolecules. 2023; 13(10).

PMID: 37892231 PMC: 10605213. DOI: 10.3390/biom13101549.

References

Nicolini C, Fahnestock M . The valproic acid-induced rodent model of autism. Exp Neurol. 2017; 299(Pt A):217-227. DOI: 10.1016/j.expneurol.2017.04.017. View

Shaaban S, El Gendy Y, Mehanna N, El-Senousy W, El-Feki H, Saad K . The role of probiotics in children with autism spectrum disorder: A prospective, open-label study. Nutr Neurosci. 2017; 21(9):676-681. DOI: 10.1080/1028415X.2017.1347746. View

Liu S, Li E, Sun Z, Fu D, Duan G, Jiang M . Altered gut microbiota and short chain fatty acids in Chinese children with autism spectrum disorder. Sci Rep. 2019; 9(1):287. PMC: 6342986. DOI: 10.1038/s41598-018-36430-z. View

Silva Y, Bernardi A, Frozza R . The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication. Front Endocrinol (Lausanne). 2020; 11:25. PMC: 7005631. DOI: 10.3389/fendo.2020.00025. View

Kang D, Adams J, Gregory A, Borody T, Chittick L, Fasano A . Microbiota Transfer Therapy alters gut ecosystem and improves gastrointestinal and autism symptoms: an open-label study. Microbiome. 2017; 5(1):10. PMC: 5264285. DOI: 10.1186/s40168-016-0225-7. View

Yang Y, Tian J, Yang B . Targeting gut microbiome: A novel and potential therapy for autism. Life Sci. 2017; 194:111-119. DOI: 10.1016/j.lfs.2017.12.027. View

Kovatcheva-Datchary P, Nilsson A, Akrami R, Lee Y, De Vadder F, Arora T . Dietary Fiber-Induced Improvement in Glucose Metabolism Is Associated with Increased Abundance of Prevotella. Cell Metab. 2015; 22(6):971-82. DOI: 10.1016/j.cmet.2015.10.001. View

Hamlin J, Pauly M, Melnyk S, Pavliv O, Starrett W, Crook T . Dietary intake and plasma levels of choline and betaine in children with autism spectrum disorders. Autism Res Treat. 2014; 2013:578429. PMC: 3876775. DOI: 10.1155/2013/578429. View

Xiao Y, Zhai Q, Zhang H, Chen W, Hill C . Gut Colonization Mechanisms of and : An Argument for Personalized Designs. Annu Rev Food Sci Technol. 2020; 12:213-233. DOI: 10.1146/annurev-food-061120-014739. View

10.

Hyman S, Levy S, Myers S . Identification, Evaluation, and Management of Children With Autism Spectrum Disorder. Pediatrics. 2019; 145(1). DOI: 10.1542/peds.2019-3447. View

11.

Gao K, Mu C, Farzi A, Zhu W . Tryptophan Metabolism: A Link Between the Gut Microbiota and Brain. Adv Nutr. 2019; 11(3):709-723. PMC: 7231603. DOI: 10.1093/advances/nmz127. View

12.

Sharma A, Batra G, Saini L, Sharma S, Mishra A, Singla R . Valproic Acid and Propionic Acid Modulated Mechanical Pathways Associated with Autism Spectrum Disorder at Prenatal and Neonatal Exposure. CNS Neurol Disord Drug Targets. 2021; 21(5):399-408. DOI: 10.2174/1871527320666210806165430. View

13.

Abdel-Haq R, Schlachetzki J, Glass C, Mazmanian S . Microbiome-microglia connections via the gut-brain axis. J Exp Med. 2018; 216(1):41-59. PMC: 6314531. DOI: 10.1084/jem.20180794. View

14.

Shedid S, Abdel-Magied N, Saada H . Role of betaine in liver injury induced by the exposure to ionizing radiation. Environ Toxicol. 2018; 34(2):123-130. DOI: 10.1002/tox.22664. View

15.

Wang L, Christophersen C, Sorich M, Gerber J, Angley M, Conlon M . Elevated fecal short chain fatty acid and ammonia concentrations in children with autism spectrum disorder. Dig Dis Sci. 2012; 57(8):2096-102. DOI: 10.1007/s10620-012-2167-7. View

16.

Dinan T, Cryan J . The Microbiome-Gut-Brain Axis in Health and Disease. Gastroenterol Clin North Am. 2017; 46(1):77-89. DOI: 10.1016/j.gtc.2016.09.007. View

17.

Tartaglione A, Schiavi S, Calamandrei G, Trezza V . Prenatal valproate in rodents as a tool to understand the neural underpinnings of social dysfunctions in autism spectrum disorder. Neuropharmacology. 2019; 159:107477. DOI: 10.1016/j.neuropharm.2018.12.024. View

18.

Barton W, Penney N, Cronin O, Garcia-Perez I, Molloy M, Holmes E . The microbiome of professional athletes differs from that of more sedentary subjects in composition and particularly at the functional metabolic level. Gut. 2017; 67(4):625-633. DOI: 10.1136/gutjnl-2016-313627. View

19.

Li Q, Zhou J . The microbiota-gut-brain axis and its potential therapeutic role in autism spectrum disorder. Neuroscience. 2016; 324:131-9. DOI: 10.1016/j.neuroscience.2016.03.013. View

20.

Muller C, Anacker A, Veenstra-VanderWeele J . The serotonin system in autism spectrum disorder: From biomarker to animal models. Neuroscience. 2015; 321:24-41. PMC: 4824539. DOI: 10.1016/j.neuroscience.2015.11.010. View